OrbiMed’s Forward Pharma A/S American Depositary Shares FWP Stock Holding History

OrbiMed’s Portfolio FWP Stock Details FWP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-114,000	Closed	-$12M	–	148
2016 Q4	$12M	Hold	114,000	–	–	0.15%	85
2016 Q3	$16.8M	Hold	114,000	–	–	0.19%	80
2016 Q2	$14.5M	Hold	114,000	–	–	0.15%	84
2016 Q1	$13.6M	Sell	114,000 -23,229	-17%	-$2.6M	0.14%	76
2015 Q4	$18.3M	Hold	137,229	–	–	0.17%	71
2015 Q3	$22.6M	Hold	137,229	–	–	0.23%	67
2015 Q2	$36.6M	Hold	137,229	–	–	0.31%	64
2015 Q1	$27.2M	Hold	137,229	–	–	0.23%	70
2014 Q4	$20M	Buy	+137,229	New	+$19.8M	0.19%	75

Other funds holding FWP

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AIM

Assured Investment Management New York $79.5M AUM 115.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

SAM

Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

OrbiMed's FWP Position: Q1 2017 in Review

OrbiMed sold out of Forward Pharma A/S American Depositary Shares (FWP) in Q1 2017, closing a stake of 114,000 shares — an estimated $12M sold.

OrbiMed first reported a position in FWP in Q4 2014 and held it in 9 quarters. The position peaked at $36.6M in Q2 2015. 32 funds tracked by Wall St. Rank hold FWP as of Q1 2017.

OrbiMed reported no remaining Forward Pharma A/S American Depositary Shares position as of Q1 2017 after selling out during the quarter.
OrbiMed sold 114,000 Forward Pharma A/S American Depositary Shares shares in Q1 2017, an estimated $12M.
OrbiMed first reported a position in Forward Pharma A/S American Depositary Shares in Q4 2014 and held it in 9 quarters.
OrbiMed's Forward Pharma A/S American Depositary Shares position peaked at $36.6M in Q2 2015.
32 funds tracked by Wall St. Rank held Forward Pharma A/S American Depositary Shares as of Q1 2017.

Based on OrbiMed's 13F filing for Q1 2017, filed 15 May 2017.